Using MRI to Measure Blood Flow in the Eye

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of arterial spin labeling (ASL) MRI, a non-invasive imaging technique, to assess blood perfusion in the human eye. By measuring parameters such as regional blood flow and cerebral blood flow, the study aims to establish the reliability and specificity of the MRI protocol for evaluating retinal diseases. Participants will undergo MRI scans without the need for contrast agents, allowing for a safer assessment of their eye conditions. The study focuses on patients with specific optic neuropathies while ensuring they meet certain health criteria.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Carrier of target pathologies: TAO optic neuropathy, inflammatory optic neuropathy, ischemic optic neuropathy.
* no cardiovascular risk factors or other ophthalmological pathology
* adhere to the study protocol after reading the patient information document
* signe the informed consent form to participate in the study
* do not have any contraindications to an MRI examination

Exclusion criteria

* Usual contraindications to MRI (Pacemaker, Metallic foreign body, Cochlear implant,…)
* Severe claustrophobia

Where it's running

• Cliniques Universitaires Saint Luc
  Brussels, Brussels Capital, Belgium Recruiting

Study contacts

• Principal investigator: Idil Günes-Tatar, MD — Cliniques universitaires Saint-Luc- Université Catholique de Louvain
• Study coordinator: Idil Günes-Tatar, MD
• Email: idil.gunes@saintluc.uclouvain.be
• Phone: +32.276442544

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Hyperspectral imaging to map retinal and optic nerve structures

  This study will test whether hyperspectral retinal imaging can detect disease-related features in adults with diabetic retinopathy, glaucoma, age-related macular degeneration, and in healthy volunteers.

  Recruiting Center for Eye Research Australia · Melbourne, Victoria · NCT07555574

• Dapagliflozin (an SGLT2 inhibitor) for slowing geographic atrophy in dry AMD

  This trial will test whether taking dapagliflozin once daily can slow the growth of geographic atrophy in people aged 50 and older with dry age-related macular degeneration.

  Recruiting Phase 2 Washington University School of Medicine · St Louis, Missouri · NCT07174687

• 4D microscope-integrated OCT imaging using the Zeiss Artevo 800 during eye surgery

  This pilot will try a 4D microscope-integrated OCT system on adults having eye surgery to see if it safely captures useful images of eye microanatomy during operations.

  Recruiting Duke University · Durham, North Carolina · NCT07024719

• Using AI to diagnose retinal diseases in real-world settings

  This study is testing whether an AI program can accurately diagnose retinal diseases like diabetic retinopathy and age-related macular degeneration using pictures of the retina taken by trained operators.

  Recruiting Beijing Tongren Hospital · Beijing, Beijing Municipality · NCT05981950

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.